Using inverse-weighting in cost-effectiveness analysis with censored data (Q5424166): Difference between revisions

From MaRDI portal
Created claim: Wikidata QID (P12): Q30760278, #quickstatements; #temporary_batch_1712190744730
Normalize DOI.
 
(One intermediate revision by one other user not shown)
Property / DOI
 
Property / DOI: 10.1191/0962280202sm308ra / rank
Normal rank
 
Property / cites work
 
Property / cites work: Estimating Medical Costs from Incomplete Follow-Up Data / rank
 
Normal rank
Property / cites work
 
Property / cites work: Linear regression analysis of censored medical costs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Estimating medical costs with censored data / rank
 
Normal rank
Property / cites work
 
Property / cites work: A regression-based method for estimating mean treatment cost in the presence of right-censoring / rank
 
Normal rank
Property / cites work
 
Property / cites work: On Estimating Medical Cost and Incremental Cost-Effectiveness Ratios with Censored Data / rank
 
Normal rank
Property / cites work
 
Property / cites work: A consistent estimator for the distribution of quality adjusted survival time / rank
 
Normal rank
Property / cites work
 
Property / cites work: Efficient Estimation of the Distribution of Quality‐Adjusted Survival Time / rank
 
Normal rank
Property / cites work
 
Property / cites work: Testing Equality of Survival Functions of Quality-Adjusted Lifetime / rank
 
Normal rank
Property / DOI
 
Property / DOI: 10.1191/0962280202SM308RA / rank
 
Normal rank

Latest revision as of 17:58, 30 December 2024

scientific article; zbMATH DE number 5208013
Language Label Description Also known as
English
Using inverse-weighting in cost-effectiveness analysis with censored data
scientific article; zbMATH DE number 5208013

    Statements

    Identifiers